These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28130887)

  • 1. Neural correlates of apathy in late-life depression: a pilot [
    Eyre HA; Siddarth P; van Dyk K; St Cyr N; Baune BT; Barrio JR; Small GW; Lavretsky H
    Psychogeriatrics; 2017 May; 17(3):186-193. PubMed ID: 28130887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
    Lavretsky H; Siddarth P; Kepe V; Ercoli LM; Miller KJ; Burggren AC; Bookheimer SY; Huang SC; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2009 Jun; 17(6):493-502. PubMed ID: 19472439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome.
    Nelson LD; Siddarth P; Kepe V; Scheibel KE; Huang SC; Barrio JR; Small GW
    Arch Neurol; 2011 Jun; 68(6):768-74. PubMed ID: 21670401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.
    Chen ST; Siddarth P; Saito NY; Rueda F; Haight T; Ercoli LM; Miller KJ; Lavretsky H; Barrio JR; Bookheimer SY; Small GW; Merrill DA
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):362-9. PubMed ID: 23567426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Krause-Sorio B; Siddarth P; Laird KT; Ercoli L; Narr K; Barrio JR; Small G; Lavretsky H
    Int Psychogeriatr; 2021 Feb; 33(2):149-156. PubMed ID: 31969201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding.
    Tolboom N; van der Flier WM; Yaqub M; Boellaard R; Verwey NA; Blankenstein MA; Windhorst AD; Scheltens P; Lammertsma AA; van Berckel BN
    J Nucl Med; 2009 Sep; 50(9):1464-70. PubMed ID: 19690025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
    Barrio JR; Kepe V; Satyamurthy N; Huang SC; Small G
    J Nutr Health Aging; 2008 Jan; 12(1):61S-5S. PubMed ID: 18165848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
    Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
    Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.
    Agdeppa ED; Kepe V; Petri A; Satyamurthy N; Liu J; Huang SC; Small GW; Cole GM; Barrio JR
    Neuroscience; 2003; 117(3):723-30. PubMed ID: 12617976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding in patients with late-life depression.
    Kumar A; Kepe V; Barrio JR; Siddarth P; Manoukian V; Elderkin-Thompson V; Small GW
    Arch Gen Psychiatry; 2011 Nov; 68(11):1143-50. PubMed ID: 22065530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    Marshall GA; Gatchel JR; Donovan NJ; Muniz MC; Schultz AP; Becker JA; Chhatwal JP; Hanseeuw BJ; Papp KV; Amariglio RE; Rentz DM; Sperling RA; Johnson KA
    J Alzheimers Dis; 2019; 67(2):757-768. PubMed ID: 30689584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia.
    Merrill DA; Siddarth P; Saito NY; Ercoli LM; Burggren AC; Kepe V; Lavretsky H; Miller KJ; Kim J; Huang SC; Bookheimer SY; Barrio JR; Small GW
    Int Psychogeriatr; 2012 Jul; 24(7):1076-84. PubMed ID: 22335970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.
    Merrill DA; Siddarth P; Raji CA; Emerson ND; Rueda F; Ercoli LM; Miller KJ; Lavretsky H; Harris LM; Burggren AC; Bookheimer SY; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2016 Sep; 24(9):729-37. PubMed ID: 27421618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.
    Buongiorno M; Antonelli F; Compta Y; Fernandez Y; Pavia J; Lomeña F; Ríos J; Ramírez I; García JR; Soler M; Cámara A; Fernández M; Basora M; Salazar F; Sanchez-Etayo G; Valldeoriola F; Barrio JR; Marti MJ
    J Alzheimers Dis; 2017; 55(3):1261-1272. PubMed ID: 27814297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial.
    Small GW; Siddarth P; Li Z; Miller KJ; Ercoli L; Emerson ND; Martinez J; Wong KP; Liu J; Merrill DA; Chen ST; Henning SM; Satyamurthy N; Huang SC; Heber D; Barrio JR
    Am J Geriatr Psychiatry; 2018 Mar; 26(3):266-277. PubMed ID: 29246725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
    Small GW; Siddarth P; Kepe V; Ercoli LM; Burggren AC; Bookheimer SY; Miller KJ; Kim J; Lavretsky H; Huang SC; Barrio JR
    Arch Neurol; 2012 Feb; 69(2):215-22. PubMed ID: 22332188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.
    Kepe V; Ghetti B; Farlow MR; Bresjanac M; Miller K; Huang SC; Wong KP; Murrell JR; Piccardo P; Epperson F; Repovs G; Smid LM; Petric A; Siddarth P; Liu J; Satyamurthy N; Small GW; Barrio JR
    Brain Pathol; 2010 Mar; 20(2):419-30. PubMed ID: 19725833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.